is a counsel located at the CMS Hamburg office and member of the CMS life sciences/intellectual property team. Susanne has particular expertise in advising on product liability and healthcare advertising law as well as related regulatory matters. She has also recently advised German, Canadian and US companies on regulatory issues concerning medicinal cannabis (such as regulatory structures for new businesses, necessary applications for an authorisation and advertising of medicinal cannabis). Furthermore, she advises companies regarding the distribution of CBD products. Latest publications: Comment on the judgment ECJ C-663/18 (A&R 2020, 284); Landmark ECJ judgement – CBD is not a narcotic (www.startupvalley.news).
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.